Dr. Miller's Presentations

 

| By Audience Type | By State/Area |

 

Click on Flag to Go to State/Area Listing

 

Washington DC Area or National:

	"Health Benefits Laws & Legislation," George Washington University School of Law, "Employment Law," Washington, DC, November 10, 2003
	Briefing Moderator, "The Long Road to Discovery: The Challenging Search for New Cures for Cancer,"  Washington, DC, June 24, 2003
	Fox Cable News, "Purchasing Medicines from Canada," January 14, 2003
	“Prescription Drugs, Prices and TV Ads,” National Public Radio, “Talk of the Nation,” April 9, 2002  [listen from NPR audio]
	Participant, “Science and Technology for National Security: The Next 50 Years,” Center for Global Security Research: Lawrence Livermore National Laboratory, Arlington, VA May 7-8, 2002
	“Pharmaceutical Innovation & Issues,” The New England Council Congressional Staff Briefing, 1116 Longworth House Office Building, Washington, DC, January 30, 2002
	“Pharmaceutical Issues in Washington – The Industry View,” American Osteopathic Association Council on Federal Health Programs, Washington, DC, January 18, 2002
	Testimony Before the United States Senate’s Committee on Veterans’ Affairs, Hearing on Prescription Drug Issues in the Department of Veterans Affairs, July 24, 2001
	“Pharmaceutical Industry Issues,” Georgetown Policy & Business in Medicine Seminar, Georgetown University School of Medicine, January 12, 2001
	“Utilizing Manufacturer Patient Assistance Programs: New Industry Efforts and Provider Feedback,” 340B Coalition Annual Conference, Washington, DC, July 20, 2000
	“Access to Prescription Drugs, Pharmaceutical Research & Quality Healthcare,” Northern Virginia Access to Health Care Consortium, Annandale, VA, May 25, 2000
	“Quality Health Care: The Right Drug for the Right Patient at the Right Time,” Foundation for Veterans’ Healthcare, “Veterans Healthcare: A New Millennium, A New Administration, A New Approach?” Washington, DC, May 11, 2000
	“It’s About Coverage, Not Price,” Public Relations Society of America Health Academy Meeting “Improved Health Care: At What Cost?,” Washington, DC, April 13, 2000
	“The Value of Innovation – For Patients, the Health Care System, and Society,” Public Relations Society of America Health Academy Meeting “Improved Health Care: At What Cost?” Washington, DC, April 13, 2000
	“Medicare & Prescription Drugs,” National Alliance for the Mentally Ill Legislative and Leadership Conference, Washington, DC, February 7, 2000 [top of page]

Arizona: 

“Prescription Drugs – Overview & Updates,” John C. Lincoln Health Network and Medical Staff Retreat, Sedona, AZ, June 3, 2000 [top of page]

Arkansas:

“Pharmaceuticals: Access, Costs and Other Issues,” Arkansas Society of the American College of Osteopathic Family Physicians, Hot Springs, AR, March 21, 2002 [top of page]

California:

	"Tele-ICU Technology Profile," Presentation to New England Healthcare Institute's FAST Initiative Steering Committee, San Francisco CA, May 11, 2006
	Participant, "The Biological Challenge: Exploiting the Opportunities and Managing the Risks" Center for Global Security Research; Chemical, Biological Arms Control Institute; International Institute for Strategic Studies, Lawrence Livermore National Laboratory, April 11-12, 2002
	Participant, “Science and Technology for National Security: The Next 50 Years,” Center for Global Security Research: Lawrence Livermore National Laboratory, March 12-13, 2002
	"Pharmaceutical Industry Issues: Access, Costs, R&D, and Information," The Forum for Medical Affairs, AMA House of Delegates Meeting, San Francisco, CA, December 3, 2001
	“Global Access to Affordable Treatment: The Current Medications Controversy,” 13th Annual HIV/AIDS Update Conference, San Francisco, CA, March 23, 2001 [top of page]

Florida:

	“Finding Cures for Heart Disease Through Innovative Pharmaceutical Research,” Nova Southeastern University, Fort Lauderdale, FL, February 8, 2001
	“Medicare & Prescription Drugs: Year 2000 and Beyond,” AACE Corporate Advisory Board, Jacksonville, FL, February 4, 2000

Georgia:

“Medication Development and Approval Process,” Georgia Academy of Family Physicians 53rd Annual Scientific Assembly, Atlanta, GA, December 1, 2001 [top of page]

Illinois:

"The Future of the US Healthcare System," Keynote Address to the Organization of State Medical Association Presidents, Chicago, IL, June 13, 2003

[top of page]

Kentucky:

"State and National Pharmaceutical Issues,” Southeastern Socioeconomic and Family Practice Forum, Louisville, KY, August 10, 2001 [top of page]

Maryland:

“Health System Reform,” MedChi (Maryland Medical Society) Health System Reform Task Force, Kent Island, MD, July 14, 2001 [top of page]

Massachusetts:

	"Implications of the Next Presidential Administration for Life Sciences Companies," Yale Life Sciences Alumni Association, Boston, MA, October 21, 2008
	"Rising Health Policy Leaders Forum," Massachusetts General Hospital Department of Medicine, May 8, 2008
	"AAAS Science and Technology Policy Fellowship Workshop," Panel Presentation at AAAS Annual Meeting, Boston MA, February 16, 2008
	"Pricing and Reimbursement as Factors for Life Science Company's Valuation," MIT Enterprise Forum of Cambridge's Life Sciences Special Interest Group," March 14, 2005
	“Insights to Marketing: Career Advice & Professional Experiences,” Simmons Consulting Group, Simmons School of Management, Boston MA, February 14, 2005
	"Life Sciences Business Creation," NETS - New Entrepreneur in Technology and Science, SHARE / Consulate of Switzerland, Cambridge MA, June 14, 2004
	"From Idea to Reality: Turning a Lab Discovery into a Commercial Product," Tufts University Bioengineering Center & Biomedical Engineering Department, February 27, 2004
	"Pharmaceutical-Biotech Intellectual Property & Market Issues," Wolf, Greenfield & Sacks, Boston, MA, June 19, 2003
	"Public Policy and The Media: What's the Story," Tufts University Friedman School of Nutrition Science and Policy, NUTR0240-01: Theories of Public Policy, April 16, 2003
	"Roles and Responsibilities of Non-Profit Boards & Board Members," Williams College Winter Study Class, “Philanthropy and The Social Entrepreneur,” January 22, 2003
	“The Patient and the Pharmaceutical Industry?  David and Goliath Without the Happy Ending,” 10th Annual Peter Mareb Lecture Series at Stonehill College’s Martin Institute for Law and Society, Easton, MA, April 26, 2001 [ top of page]

Missouri:

	Testimony Before Missouri House of Representatives Interim Committee on Access to Affordable Prescription Drugs for Senior Citizens, St. Louis, MO, December 5, 2000
	“Update on Medicare & Prescription Drugs Issues: Looking to 2001 and Beyond,” AACE Corporate Advisory Board, St. Louis, MO, November 3, 2000 [top of page]

New York:

	“Prescription Drug ‘Costs’,” Empire State Report’s 6th Annual Healthcare Conference, New York, NY, May 24, 2001
	“Affordable Prescription Drugs: Why? Why Not?” Manhattan Borough-Wide Inter-Agency Council On Aging, Sixth Annual Breakfast Forum, Terence Cardinal Cooke Health Care Center, New York, NY, October 20, 2000 [top of page]

Oklahoma:

“Prescription Drug Cost and Access: Pharmaceutical Industry Perspective,” Oklahoma State Medical Association 95th Annual Meeting, Saturday April 28, 2001 [top of page]

Pennsylvania:

	"The Pharmaceutical Industry's Contribution to Economic Development and Prosperity in Pennsylvania," Testimony Before House Majority Policy Committee Hearing, Sub-Committee on Prescription Drugs (PACE/PACENET), Folsom, PA, July 16, 2002
	“The Pharmaceutical Industry,” Community and Preventive Medicine Course Seminar on Healthcare Financing, Services and Delivery: Survival Skills for Future Physicians, MCP/Hahnemann School of Medicine January 5, 2001
	”Smart Talk: Prescription Drugs After the Election,” WITF-TV, PBS Affiliate, Harrisburg, PA, November 2, 2000
	“Senior Prescription Drug Cost Breakfast and Seminar,” Breakfast Seminar for Senior Citizens Organized by Pennsylvania State Representative Charles T. McIlhinney, Jr., Doylestown, PA, October 14, 2000
	“AARP Town Hall Meeting on Prescription Drug Issues,” Federal Reserve Bank, Philadelphia, PA, September 19, 2000 [top of page]

Rhode Island:

"Healthcare Policy & Politics," Brown University Department of Political Science and Public Policy, "PS 110: Congress and Public Policy," March 6, 2003

[top of page]

Tennessee:

“Trends and Treatments in Women’s Health,” Keynote Address, Senior Women’s Health Forum Baptist Hospital, Nashville, TN, June 8, 2000 [top of page]

Texas:

	“The Production of Pharmaceuticals Overseas:  Implications for US Physicians and Patients,” American Association of Clinical Endocrinologists (AACE) Corporate Advisory Board, San Antonio, TX, May 2, 2001
	“Walking the Tightrope: Stretching the Pharmacy Dollar,” Panel, Texas Pharmacy Association Annual Meeting, Austin, TX, June 23, 2000
	“Overview of the Pharmaceutical Market – Prescription Drugs & Healthcare: Year 2000 and Beyond,” HMO Alliance Board of Directors Meeting, Dallas, TX, February 24, 2000 [top of page]

Vermont:

	“Access: What is Being Done,” BlueCross BlueShield of Vermont and The Vermont Health Plan Meeting on “Understanding the Cost of Drugs,” Burlington, VT, October 24, 2000
	“Reaction Panel:  An In-Depth Look at Price,” BlueCross BlueShield of Vermont and The Vermont Health Plan Meeting on “Understanding the Cost of Drugs,” Burlington, VT, October 24, 2000
	”What Can Be Done to Reduce Prescription Drug Bills Now?” Community Forum Hosted by Vermont State Representatives Margaret Flory, Kevin Mullin and Thomas Depoy, Godnick Adult Center, Rutland, VT, October 17, 2000 [top of page]

Virginia:

	“Value in Healthcare: Unraveling the Equation,” Virginia Association of Health Underwriters, Richmond, VA, April 23, 2002
	“What Can We Do About Drug Costs?,” Panel Discussion at Central Shenandoah Valley Health Care Coalition Annual Seminar “Employers’ Perspectives on Health Care Costs: Nowhere But Up?,” Staunton, VA, December 1, 2000
	“Medicare & Prescription Drugs:  2000 and Beyond,” Virginia Quality Healthcare Network, Richmond, VA, May 12, 2000 [top of page]

Washington: 

“Prescription Drug: How Can We Balance Care, Costs and Access?,” The O’Connor Report Invitational Healthcare Leadership Forum, Seattle, WA, June 1, 2001

 

[top of page]

---

For a more extensive description of Dr. Miller's background and experiences go to Resume